{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:00:08Z","timestamp":1761512408598},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[1999,3]]},"DOI":"10.1007\/s11906-999-0013-x","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T05:34:20Z","timestamp":1180071260000},"page":"158-163","source":"Crossref","is-referenced-by-count":14,"title":["The epithelial sodium channel in hypertension"],"prefix":"10.1007","volume":"1","author":[{"given":"David G.","family":"Warnock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"13_CR1","first-page":"199","volume":"76","author":"GW Liddle","year":"1963","unstructured":"Liddle GW, Bledsoe T, Coppage WS: A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Am Assoc Physicians 1963, 76:199\u2013213.","journal-title":"Trans Am Assoc Physicians"},{"key":"13_CR2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1056\/NEJM199401203300305","volume":"330","author":"M Botero-Velez","year":"1994","unstructured":"Botero-Velez M, Curtis JJ, Warnock DG: Brief report: Liddle\u2019s syndrome revisited. N Engl J Med 1994, 330:178\u2013181.","journal-title":"N Engl J Med"},{"key":"13_CR3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1523-1755.1998.00728.x","volume":"53","author":"DG Warnock","year":"1998","unstructured":"Warnock DG: Liddle syndrome: an autosomal dominant form of human hypertension. Kidney Intern 1998, 53:18\u201324. Detailed description of the clinical presentation and pathophysiologic basis for pseudoaldosteronism.","journal-title":"Kidney Intern"},{"key":"13_CR4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1681\/ASN.V86980","volume":"8","author":"BC Rossier","year":"1997","unstructured":"Rossier BC: Cum grano salis: the epithelial sodium channel and the control of blood pressure. J Amer Soc Nephrol 1997, 8:980\u2013992. Homer Smith Lecture describing the expression cloning of ENaC and the genetic disorders of its regulation.","journal-title":"J Amer Soc Nephrol"},{"key":"13_CR5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0092-8674(94)90250-X","volume":"79","author":"RA Shimkets","year":"1994","unstructured":"Shimkets RA, Warnock DG, Bositis CM, et al.: Liddle\u2019s syndrome: heritable human hypertension caused by mutations in the b subunit of the epithelial sodium channel. Cell 1994, 79:407\u2013414.","journal-title":"Cell"},{"key":"13_CR6","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/j.1460-2075.1996.tb00594.x","volume":"15","author":"L Schild","year":"1996","unstructured":"Schild L, Lu Y, Gautschi I, et al.: Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle\u2019s syndrome. EMBO J 1996, 15:2381\u20132387.","journal-title":"EMBO J"},{"key":"13_CR7","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1002\/j.1460-2075.1996.tb00593.x","volume":"15","author":"O Staub","year":"1996","unstructured":"Staub O, Dho S, Henry PC, et al.: WW domains of Nedd4 bind to the proline-rich PY motifs in the epithelial Na+ channel deleted in Liddle\u2019s syndrome. EMBO J 1996, 15:2371\u20132380.","journal-title":"EMBO J"},{"key":"13_CR8","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1093\/emboj\/16.21.6325","volume":"16","author":"O Staub","year":"1997","unstructured":"Staub O, Gautschi I, Ishikawa T, et al.: Regulation of stability and function of the epithelial Na+ channel (ENaC) by ubiquitination. EMBO J 1997, 16:6325\u20136336. Cell biologic description of one pathway by which the expression of ENaC is controlled at the plasma membrane level.","journal-title":"EMBO J"},{"key":"13_CR9","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0092-8674(95)90212-0","volume":"83","author":"PM Snyder","year":"1995","unstructured":"Snyder PM, Price M, McDonald FJ, et al.: Mechanism by which Liddle\u2019s syndrome mutations increase activity of a human epithelial Na+ channel. Cell 1995, 83:969\u2013978.","journal-title":"Cell"},{"key":"13_CR10","doi-asserted-by":"crossref","first-page":"15370","DOI":"10.1073\/pnas.93.26.15370","volume":"93","author":"D Firsov","year":"1996","unstructured":"Firsov D, Schild L, Gautschi I, et al.: Cell surface expression of the epithelial Na channel and a mutatant causing Liddle syndrome: a quantitative approach. Proc Natl Acad Sci U S A 1996, 93:15370\u201315375.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13_CR11","doi-asserted-by":"crossref","first-page":"25537","DOI":"10.1074\/jbc.272.41.25537","volume":"272","author":"RA Shimkets","year":"1997","unstructured":"Shimkets RA, Lifton RP, Canessa CM: The activity of the epithelial sodium channel is regulated by clathrin-mediated endocytosis. J Biol Chem 1997, 272:25537\u201325541.","journal-title":"J Biol Chem"},{"key":"13_CR12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0960-0760(93)90132-G","volume":"45","author":"CH Shackleton","year":"1993","unstructured":"Shackleton CH: Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research. J Steroid Biochem Molec Biol 1993, 45:127\u2013140.","journal-title":"J Steroid Biochem Molec Biol"},{"key":"13_CR13","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1681\/ASN.V7122543","volume":"7","author":"YR Su","year":"1996","unstructured":"Su YR, Rutkowski MP, Klanke CA, et al.: novel variant of the \u00dfsubunit of the amiloride-sensitive sodium channel in African Americans. J Am Soc Nephrol 1996, 7:2543\u20132549.","journal-title":"J Am Soc Nephrol"},{"key":"13_CR14","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(97)07306-6","volume":"351","author":"EH Baker","year":"1998","unstructured":"Baker EH, Dong YB, Sagnella GA, et al.: Association of hypertension with T594M mutation in the b subunit of epithelial sodium channels in black people resident in London. Lancet 1998, 351:1388\u20131392. Provocative report of polymorphisms in the ENaC beta subunit, and a genetic association to hypertension in blacks.","journal-title":"Lancet"},{"key":"13_CR15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/ng0396-248","volume":"12","author":"SS Chang","year":"1996","unstructured":"Chang SS, Grunder S, Hanukoglu A, et al.: Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet 1996, 12:248\u2013253.","journal-title":"Nat Genet"},{"key":"13_CR16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/ng0696-248","volume":"13","author":"SS Strautnieks","year":"1996","unstructured":"Strautnieks SS, Thompson RJ, Gardiner R. M, et al.: A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families. Nat Genet 1996, 13:248\u2013250.","journal-title":"Nat Genet"},{"key":"13_CR17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/966","volume":"19","author":"DS Geller","year":"1998","unstructured":"Geller DS, Rodriquez-Soriano J, Boado AV, et al.: Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism, type I. Nat Genet 1998, 19:279\u2013281. Authoritative distinction between the dominant and recessive forms of pseudohypoaldosteronism, type I.","journal-title":"Nat Genet"},{"key":"13_CR18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0960-0760(96)00176-8","volume":"60","author":"A Hanukoglu","year":"1997","unstructured":"Hanukoglu A, Joy O, Steinitz M, et al.: Pseudohypoaldosteronism due to renal and multisystem resistance to mineralocorticoids respond differently to carbenoxolone. J Steroid Biochem Molec Biol 1997, 60:105\u2013112.","journal-title":"J Steroid Biochem Molec Biol"},{"key":"13_CR19","first-page":"2263","volume":"80","author":"RC Wilson","year":"1995","unstructured":"Wilson RC, Krozowski ZS, Li K, et al.: A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1995, 80:2263\u20132266.","journal-title":"J Clin Endocrinol Metab"},{"key":"13_CR20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/ng0895-394","volume":"10","author":"T Mune","year":"1995","unstructured":"Mune T, Rogerson FM, Nikkila H, et al.: Human hypertension caused by mutations in the kidney isozyme of 11 betahydroxysteroid dehydrogenase. Nat Genet 1995, 10:394\u2013399.","journal-title":"Nat Genet"},{"key":"13_CR21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2265.1992.tb01478.x","volume":"37","author":"BR Walker","year":"1992","unstructured":"Walker BR, Campbell JC, Fraser R, et al.: Mineralocorticoid excess and inhibition of 11b-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin Endocrinol 1992, 37:483\u2013492.","journal-title":"Clin Endocrinol"},{"key":"13_CR22","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","volume":"242","author":"JW Funder","year":"1987","unstructured":"Funder JW, Pearce PT, Smith AT: Mineralocorticoid action: target tissue specificity is enzyme, not receptor mediated. Science 1987, 242:583\u2013585.","journal-title":"Science"},{"key":"13_CR23","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(87)91014-2","volume":"2","author":"PM Stewart","year":"1987","unstructured":"Stewart PM, Valentino R, Wallace AM, et al.: Mineralocorticoid activity of liquorice: 11b-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 1987, 2:821\u2013824.","journal-title":"Lancet"},{"key":"13_CR24","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0024-3205(96)00417-1","volume":"59","author":"DJ Edwards","year":"1996","unstructured":"Edwards DJ, Bernier SM: Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice. Life Sci 1996, 59:1025\u20131030.","journal-title":"Life Sci"},{"key":"13_CR25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0009-9236(96)90025-9","volume":"59","author":"YS Lee","year":"1996","unstructured":"Lee YS, Lorenzo BJ, Koufis T, et al.: Grapefruit juice and its flavinoids inhibit 11b-hydroxysteroid dehydrogenase. Clin Pharmacol Ther 1996, 59:62\u201371.","journal-title":"Clin Pharmacol Ther"},{"key":"13_CR26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/cs0780049","volume":"78","author":"PM Stewart","year":"1990","unstructured":"Stewart PM, Atherden SM, Shearing CH, et al.: Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11b-hydroxysteroid dehydrogenase activity in man. Clin Sci 1990, 78:49\u201354.","journal-title":"Clin Sci"},{"key":"13_CR27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1440-1681.1996.tb02744.x","volume":"23","author":"MC Ingram","year":"1996","unstructured":"Ingram MC, Wallace AM, Collier A, et al.: Sodium status, corticosteroid metabolism and blood pressure in normal human subjects and in a patient with abnormal salt appetite. Clin Exp Pharmacol Physiol 1996, 23:375\u2013378.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"13_CR28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2265.1993.tb01778.x","volume":"39","author":"BR Walker","year":"1993","unstructured":"Walker BR, Stewart PM, Shackleton CHL, et al.: Deficient inactivation of cortisol by 11b-hydroxysteroid dehydrogenase in essential hypertension. Clin Endocrinol 1993, 39:221\u2013227.","journal-title":"Clin Endocrinol"},{"key":"13_CR29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.HYP.25.1.67","volume":"25","author":"A Soro","year":"1995","unstructured":"Soro A, Ingram MC, Tonolo G, et al.: Evidence of coexisting changes in 11b-hydroxysteroid dehydrogenase and 5b reductase activity in subjects with untreated essential hypertension. Hypertension 1995, 25:67\u201370.","journal-title":"Hypertension"},{"key":"13_CR30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1681\/ASN.V92322","volume":"9","author":"B Dick","year":"1998","unstructured":"Dick B, Sharma AM Schorr U, et al.: Salt-sensitivity is associated with impaired 11b-hydroxy-steroid dehydrogenase type 2 activity in humans [abstract]. J Am Soc Nephrol 1998, 9:322. Preliminary report suggesting that there may be a genetic association between salt-sensitive hypertension and human 11b-hydroxy-steroid dehydrogenase, type 2 activity.","journal-title":"J Am Soc Nephrol"},{"key":"13_CR31","first-page":"1814","volume":"83","author":"Z Smolenicka","year":"1998","unstructured":"Smolenicka Z, Bach E, Schaer A, et al.: A new polymorphic restriction site in the human 11 beta-hydroxysteroid dehydrogenase type 2 gene. J Clin Endocrinol Metab 1998, 83:1814\u20131817. Simple bi-allelic polymorphism in an important candidate gene in human low renin hypertension.","journal-title":"J Clin Endocrinol Metab"},{"key":"13_CR32","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/01.HYP.28.3.478","volume":"28","author":"BJ Watson","year":"1996","unstructured":"Watson BJ, Bergman SM, Myracle A, et al.: Genetic Association of 11 beta-hydroxysteroid dehydrogenase type 2 (HSD11B2) flanking microsatellites with essential hypertension in blacks. Hypertension 1996, 28:478\u2013482. Flanking microsatellites and allelic frequencies for an important candidate gene in blacks with low renin hypertension.","journal-title":"Hypertension"},{"key":"13_CR33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng0992-66","volume":"2","author":"RP Lifton","year":"1992","unstructured":"Lifton RP, Dluhy RG, Powers M, et al.: Hereditary hypertension caused by chimeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet 1992, 2:66\u201374.","journal-title":"Nat Genet"},{"key":"13_CR34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","volume":"355","author":"RP Lifton","year":"1992","unstructured":"Lifton RP, Dluhy RG, Powers M, et al.: A chimaeric 11 b-hydroxylase\/ aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992, 355:262\u2013265.","journal-title":"Nature"},{"key":"13_CR35","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1172\/JCI118279","volume":"96","author":"L Pascoe","year":"1995","unstructured":"Pascoe L, Jeunemaitre X, Lebrethon M-C, et al.: Glucocorticoidsuppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. J Clin Invest 1995, 96:2236\u20132246.","journal-title":"J Clin Invest"},{"key":"13_CR36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.7326\/0003-4819-116-10-813","volume":"116","author":"G Rich","year":"1992","unstructured":"Rich G, Ulick S, Cook S, et al.: Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype. Ann Int Med 1992, 116:813\u2013820.","journal-title":"Ann Int Med"},{"key":"13_CR37","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/07435809609043764","volume":"22","author":"JMC Connell","year":"1996","unstructured":"Connell JMC, Jamieson AJ, Davies E, et al.: 11b-hydroxylase activity in glucocorticoid suppressible hyperaldosteronism: lessons for essential hypertension. Endocrinol Res 1996, 22:691\u2013700.","journal-title":"Endocrinol Res"},{"key":"13_CR38","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/01.HYP.28.6.927","volume":"28","author":"PC White","year":"1996","unstructured":"White PC: Inherited forms of mineralocorticoid hypertension. Hypertension 1996, 28:927\u2013936.","journal-title":"Hypertension"},{"key":"13_CR39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000174773","volume":"78","author":"I Komiya","year":"1991","unstructured":"Komiya I, Yamada T, Aizawa T, et al.: Inappropriate elevation of the aldosterone\/plasma renin activity ratio in hypertensive patients and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension? Cardiology 1991, 78:99\u2013110.","journal-title":"Cardiology"},{"key":"13_CR40","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.272.5262.676","volume":"272","author":"RP Lifton","year":"1996","unstructured":"Lifton RP: Molecular genetics of human blood pressure variation. Science 1996, 272:676\u2013680.","journal-title":"Science"},{"key":"13_CR41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.nu.16.070196.002303","volume":"16","author":"CE Fardella","year":"1996","unstructured":"Fardella CE, Miller WL: Molecular biology of mineralocorticoid metabolism. Ann Rev Nutr 1996, 16:443\u2013470.","journal-title":"Ann Rev Nutr"},{"key":"13_CR42","first-page":"116","volume":"15","author":"OB Holland","year":"1995","unstructured":"Holland OB: Primary aldosteronism. Semin Nephrol 1995, 15:116\u2013125.","journal-title":"Semin Nephrol"},{"key":"13_CR43","first-page":"2298","volume":"81","author":"A Jamieson","year":"1996","unstructured":"Jamieson A, Ingram, MC, Inglis, GC, et al.: Altered 11b-hydroxylase activity in glucocorticoid-suppressible hyperaldosteronism. J Clin Endocrinol Metab 1996, 81:2298\u20132302.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-999-0013-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-999-0013-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-999-0013-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T05:37:43Z","timestamp":1628919463000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-999-0013-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,3]]}},"alternative-id":["13"],"URL":"https:\/\/doi.org\/10.1007\/s11906-999-0013-x","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,3]]}}}